Walgreens made headlines recently with the news that it was getting out of the walk-in clinic business. The news sparked interesting reactions across the industry. Some pundits pointed to managerial missteps; healthcare delivery insiders breathed a sigh of relief, while others shot a knowing smile that said, “I told you…
As a spectator of the tug-of-war between the Centers for Medicare and Medicaid Services (CMS) and the American Hospital Association (AHA) for some years now, all I can do is shake my head at the industry group’s dug-in opposition to change. In the latest face-off between the two entities, the…
As the US heads into an election year, healthcare will be in the spotlight as never before. We expect both parties will be under pressure to propose solutions that appear substantive without threatening benefits that many consumers value. The current administration is likely to continue its incremental steps toward a…
As our Numerof 2020 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about adapting to pressures on price and demands for value. You’ll continue to engage in new and different ways with regulators, public and private payers, consumers, employers, health care delivery, physicians,…
As our Numerof 2020 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value. This will create the need for changes in current roles and external relationships. You’ll continue to engage in new and different…
As our Numerof 2020 US Health Insurance Outlook infographic illustrates, this year’s story for health insurance will be about dramatically changing roles and relationships. You’ll engage in new and different ways with providers, consumers, employers, regulators, medical device makers and pharmaceutical manufacturers. All this will come in the context of…
